NEW BRUNSWICK, N.J., 6 July 2018 –Johnson & Johnson today announced that The Lancet has published key early-stage data regarding
Continue reading »
Home » Medications »
Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer
PRINCETON, N.J.– July 11, 2018 (BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy
Continue reading »
Any opioid use tied to involvement in criminal justice system
(HealthDay)—Any opioid use is associated with involvement in the criminal justice system in the past year, according to a study
Continue reading »
Taking a Daily Aspirin to Prevent a Heart Attack or Stroke? Think twice.
Benefits of aspirin Aspirin is famously known as an NSAID (non-steroidal anti-inflammatory drug) that can be used for pain, fever,
Continue reading »
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
BOSTON, June 14, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization
Continue reading »
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy
SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced data from the Phase 2
Continue reading »
US could back 1st pot-derived medicine, and some are worried
A British pharmaceutical company is getting closer to a decision on whether the U.S government will approve the first prescription
Continue reading »
Opioid dependence in patients with degenerative spondylolisthesis: More likely to occur before than after surgery
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis (DS). They found
Continue reading »
Drug shortages pose a public health crisis in the US
On June 12, the American Medical Association announced that drug shortages pose an urgent public health crisis. This crisis should
Continue reading »
Illicit opioid trade up with restrictions on hydrocodone
(HealthDay)—The U.S. Drug Enforcement Administration’s 2014 ruling to reschedule hydrocodone combination products coincided with an increase in illicit trading of
Continue reading »